OMEN Pharma

Antengene Corporation Limited (Antengene), a prominent global biopharmaceutical company, has announced a significant milestone: South Korea’s National Health Insurance Service (NHIS) has approved reimbursement for Xpovio (selinexor) starting July 1, 2024. This approval marks Xpovio’s inclusion in South Korea’s national reimbursed drugs list for treating adult patients with relapsed or refractory multiple myeloma (R/R MM). … Read more

Stalicla SA, a Swiss neuro precision biotech company specializing in precision medicine for neuropsychiatric and neurodevelopmental disorders, has announced the publication of a significant phase 1b study on STP1. This novel combination therapy is tailored for treating a specific subgroup of patients with autism spectrum disorder (ASD) known as ASD Phenotype 1 (ASD-Phen1). Published in … Read more

Pharmexcil, the Pharmaceuticals Export Promotion Council of India, is set to resume discussions with Russia’s SBER Bank in New Delhi by the end of June 2024. This meeting aims to tackle challenges faced by exporters and address issues related to the Rupee-Rouble trade arrangement, crucial for trade between India and Russia. Pharmexcil is urging its … Read more

Diabetes specialists in India are increasingly concerned about foot infections among diabetic patients, as these often lead to serious complications like lower limb amputations. Currently, about 15% of diabetics in India suffer from diabetic foot infections (DFI), which are commonly caused by bacteria like Pseudomonas, E. coli, and S. aureus. The recent guidelines from the … Read more

The All Kerala Chemists and Druggists Association (AKCDA) plans to approach District Magistrates and District Child Protection Units (DCPUs) to request an extension of the deadline for installing CCTV surveillance cameras in their shops. They also seek exemptions for small-scale traders with a daily turnover below Rs. 1,500, as well as shops located away from … Read more

In May 2024, the Production Linked Incentive (PLI) scheme for pharmaceuticals saw a notable investment of Rs. 940 crore, marking a 3.32% increase from April’s Rs. 28,328 crore to Rs. 29,268 crore. According to the Department of Pharmaceuticals (DoP), actual production surged by 12.3% in May to Rs. 1,61,209 crore, compared to Rs. 1,43,553 crore … Read more

At the Global Pharmaceutical Quality Summit-2024 in Mumbai, India’s Drugs Controller General, Rajeev Raghuvanshi, emphasized the urgent need for the pharmaceutical industry to bolster its quality management, documentation, and validation processes. He revealed that recent inspections had revealed alarming findings: approximately 36 percent of inspected pharma manufacturing units had to cease operations due to failing … Read more